Metformin study for premature babies with lung disease
Treatments studied
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests whether metformin, a medicine used for diabetes, can help premature babies with chronic lung disease (bronchopulmonary dysplasia, or BPD) breathe better. It may reduce the need for breathing machines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 29 weeks of pregnancy.
- Your baby is either 8 to 22 weeks old with a BPD diagnosis at 36 weeks corrected, OR 7 to 30 days old and needed a breathing tube or strong breathing support at day 7.
- Your baby does not have persistent low blood sugar (hypoglycemia) or lactic acidosis.
- Your baby does not have feeding problems, kidney or liver issues, or an active infection.
- Your baby does not have a birth defect that prevents feeding, and you are not choosing only comfort care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a steroid medicine called dexamethasone can help prevent a serious lung problem in very premature babies who need a breathing machine for a long time. It may help babies who are still on the machine after two weeks and need high levels of oxygen.
This trial tests whether a type of stem cell (mesenchymal stromal cells) can help prevent bronchopulmonary dysplasia, a serious lung condition, in very premature babies. Babies born before 28 weeks who are on a breathing machine with high oxygen needs may be eligible.
This study looks at whether viruses in the gut and lungs of very premature babies affect their risk of developing bronchopulmonary dysplasia (a chronic lung condition). It aims to find ways to predict or prevent this problem.
This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.
This study looks at whether a careful CPAP breathing support plan helps very premature babies breathe better. It may be an option for babies who are stable on low oxygen settings and have few breathing pauses.
This trial tests a new treatment to help very premature babies (born at 22 to nearly 29 weeks) who still need a breathing machine and extra oxygen at 1–2 weeks old. The goal is to see if it can improve their lung health and reduce the need for breathing support.
Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.